Reviews in Endocrine & Metabolic Disorders

Papers
(The H4-Index of Reviews in Endocrine & Metabolic Disorders is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review184
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality156
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus144
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review110
Traumatic brain injury and prolactin98
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb85
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?78
Diagnostic and prognostic utility of phase angle in patients with cancer74
The genetics of Graves’ disease65
Endocrine responses of the stress system to different types of exercise55
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review55
Posttranslational modifications in diabetes: Mechanisms and functions54
Prolactin deficiency in the context of other pituitary hormone abnormalities48
Preface44
Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients43
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic41
Androgens, aging, and prostate health41
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond41
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease40
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease40
No longer to be ignored: Hypophosphatemia following intravenous iron administration39
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence39
Mention to Prof. Andrew V. Schally36
Hypothalamic GHRH36
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis36
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries35
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review35
Appetitive interoception, the hippocampus and western-style diet34
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy34
Correction: Hypothalamic GHRH33
Deep neural network for food image classification and nutrient identification: A systematic review33
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome33
Towards precision medicine in non-alcoholic fatty liver disease32
Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes32
0.056583881378174